CS logo
small CS logo
Zuyderland Medisch Centrum

Heerlen, Netherlands
General hospital in Heerlen
Henri Dunantstraat 5, 6419 PC Heerlen

About Zuyderland Medisch Centrum


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Zuyderland Medisch Centrum


During the past decade, Zuyderland Medisch Centrum conducted 127 clinical trials. In the 10-year time frame, 127 clinical trials started and 43 clinical trials were completed, i.e. on average, 33.9% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 25 clinical trials were completed. i.e. 47.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1010121218181414202025251717101011003388225566888833Started TrialsCompleted Trails2015201620172018201920202021202220230102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
2001-05-01
Completed
1,000
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
2001-06-01
Completed
941
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Dose Finding Study in COPD
2005-07-01
Completed
389
A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations
2003-03-01
2005-02-01
Completed
254

Rows per page:

1–100 of 208

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Zuyderland Medisch Centrum" #1 sponsor was "Zuyderland Medisch Centrum" with 26 trials, followed by "Hoffmann-La Roche" with 19 trials sponsored, "Maastricht University Medical Center" with 15 trials sponsored, "Boehringer Ingelheim" with 12 trials sponsored and "Celgene" with 12 trials sponsored. Other sponsors include 122 different institutions and companies that sponsored additional 81 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zuyderland Medisch Centrum" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 12 trials as a collaborator, "Maastricht University Medical Center" with 8 trials as a collaborator, "Borstkanker Onderzoek Groep" with 5 trials as a collaborator, "Dutch Cancer Society" with 5 trials as a collaborator and "Zuyderland Medical Centre" with 5 trials as a collaborator. Other collaborators include 190 different institutions and companies that were collaborators in the rest 168 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Zuyderland Medisch Centrum


According to Clinical.Site data, the most researched conditions in "Zuyderland Medisch Centrum" are "Breast Cancer" (14 trials), "Crohn Disease" (8 trials), "Atrial Fibrillation" (7 trials), "Multiple Sclerosis" (6 trials) and "Prostate Cancer" (6 trials). Many other conditions were trialed in "Zuyderland Medisch Centrum" in a lesser frequency.

Clinical Trials Intervention Types at Zuyderland Medisch Centrum


Most popular intervention types in "Zuyderland Medisch Centrum" are "Drug" (129 trials), "Other" (36 trials), "Procedure" (19 trials), "Device" (17 trials) and "Biological" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (36 trials), "Atezolizumab" (5 trials), "Dexamethasone" (5 trials), "Ocrelizumab" (5 trials) and "Ozanimod" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Zuyderland Medisch Centrum


The vast majority of trials in "Zuyderland Medisch Centrum" are 166 trials for "All" genders, 30 trials for "Female" genders and 12 trials for "Male" genders.

Clinical Trials Status at Zuyderland Medisch Centrum


Currently, there are 69 active trials in "Zuyderland Medisch Centrum". 2 are not yet recruiting, 42 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 106 completed trials in Zuyderland Medisch Centrum, undefined suspended trials, and 21 terminated clinical trials to date.
Out of the total trials that were conducted in Zuyderland Medisch Centrum, 0 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 41 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status